Universal Ibogaine Inc. (IBOGF)
Universal Ibogaine Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $0.02, up 0.00% on the session, giving a market capitalisation of $7.5M. On trailing twelve-month figures it carries a trailing P/E of -0.09, a net margin of -980.2%. Its beta of 4.38 implies it has historically moved more than the broad market.
Universal Ibogaine Inc., a life sciences enterprise, focuses on developing, acquiring, and operating addiction treatment centers across Canada. The company is additionally preparing to launch clinical trials aimed at researching ibogaine's potential therapeutic applications for addiction. Its principal corporate offices are based in Calgary, Canada.
Universal Ibogaine Inc. is most often compared with the following Healthcare names: